RecruitingNot ApplicableNCT06286917
Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency
Sponsor
Tampere University
Enrollment
120 participants
Start Date
Mar 5, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This research will study whether noninvasive ventilation (NIV) used to treat chronic respiratory insufficiency in patients with amyotrophic lateral sclerosis (ALS) can be initiated as successfully in the outpatient setting as in the conventional inpatient setting, and what the costs of these alternative initiation methods are.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Inclusion Criteria2
- ALS diagnosed by a neurology and
- chronic respiratory insufficiency or significant respiratory muscle weakness caused by ALS
Exclusion Criteria4
- impaired cognition to give informed consent to participation
- contraindication to NIV therapy
- another severe disease with a prognosis of less than one year
- ventilation via an artificial airway, tracheostomy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNIV initiation in patients with ALS
NIV initiation according to standard care
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06286917
Related Trials
Improving Chronic Nocturnal Noninvasive Ventilation: a Multimodality Approach
NCT057563871 location
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
NCT043968731 location
A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS)
NCT070719353 locations
Neurologic Stem Cell Treatment Study
NCT027950523 locations
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)
NCT065119341 location